Inhibitors of PD-1 in Non-Small Cell Lung Cancer: A Meta-Analysis of Clinical and Molecular Features.

Front Immunol · 2022 · PMC9037098 · PMID 35479081

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Some studies have shown that in NSCLC, smokers have a favorable trend of PD-1 inhibitor treatment compared with non-smokers ( 65 – 67 ) and support the result of our meta-analysis.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.